 |
 
|
Asia's most prestigious antibody conference
Overview
Asia Antibody Congress 2013 will serve as a strategic platform for pharmas, biotechs, research institutes and solution providers to discuss key strategies to expedite business development, scientific advancement and partnerships for their antibody business.
Showcasing major global trends, clinical breakthroughs, best practices and 1 to 1 partnering opportunities, this event delivers unrivalled industry participation across the antibody value chain in Asia.
Key features
- 300+ Asia's leading antibody stakeholders
- 2 co-located conferences
- Over 30 international speakers
- 2 strategic and content intensive workshops
- 1 strategic platform
- 1-to-1 partnering system
More on attending ›
Register now ›
Reasons to attend
- Capitalise on Asia's potential as an antibody R&D hub and gain greater market share in this booming antibody industry
- Benefit from insights of more than 30 industry thought leaders and innovators, with presentations from Johnson & Johnson, Roche, Novartis, Amgen, MedImmune and AbbVie
- Discover and apply innovative and human disease models to understand important disease pathways and generate novel therapeutics
Who should attend
- Pharmas
- Large / SME Biotechs
- NGOs
- Invement Banks / Private Equity
- Government / Regulatory bodies
- Academia / Research Institutes
Who should sponsor
- CROs / CMOs
- Logistics Service Providers
- Platform Technology Providers
- Biotechs
- Cell Culture Service Providers
- Bioprocess Equipment Suppliers
- Reagent Suppliers
sponsors
Bronze Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Innovative Showcase Sponsor
co-located with
